Biomedical Catalyst News Today

ELRIG UK unveils the keynote speakers for its upcoming Research and Innovation conference

Keynote speakers for the European Laboratory Research & Innovation Group (ELRIG) UK, to be held at the University of Manchester from 20–21 March are Steve Bates OBE FMedSci, CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-founder and Head of R&D and Drug Development, FasT BioPharma. Click to read more...

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the keynote speakers for its upcoming Research and Innovation conference taking place at the University of Manchester from 20–21 March. Steve Bates OBE FMedSci, CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-founder and ...

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the keynote speakers for its upcoming Research and Innovation conference taking place at the University of Manchester from 20–21 March.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Newcastle firm LightOx has received a grant of more than £1million to continue their revolutionary work to tackle oral cancer.

START-up firm AilseVax, which is developing the next generation of cancer vaccines, has become the 100th company to spin out of the laboratories at Belfast's Queen’s University.

Queen’s University Belfast has announced its 100th spin-out company - AilseVax - with seed funding of £1.5M from a group of investors.